BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/26/2024 8:22:29 AM | Browse: 113 | Download: 428
 |
Received |
|
2024-08-01 14:46 |
|
Peer-Review Started |
|
2024-08-01 14:46 |
|
First Decision by Editorial Office Director |
|
2024-08-17 03:14 |
|
Return for Revision |
|
2024-08-17 03:14 |
|
Revised |
|
2024-08-30 13:11 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-09-13 02:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-09-13 05:59 |
|
Articles in Press |
|
2024-09-13 05:59 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-09-19 01:36 |
|
Publish the Manuscript Online |
|
2024-09-26 08:22 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Dual peroxisome proliferator-activated receptor α/δ agonists: Hope for the treatment of alcohol-associated liver disease?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xin-Yang Zhang, Qin-JunJie Chen, Feng Zhu, Min Li and Dan Shang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82172754, 81874208 |
| Natural Science Foundation Project of Hubei Province |
2021CFB562 |
|
| Corresponding Author |
Dan Shang, MD, PhD, Associate Professor, Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan 430022, Hubei Province, China. danshang@hust.edu.cn |
| Key Words |
Peroxisome proliferator-activated receptor; Elafibranor; Antifibrotic effect; Fibrosis; Alcohol-associated liver disease |
| Core Tip |
Alcohol-associated liver disease (ALD) is a common disease with an annually increasing incidence. It is the primary cause of cirrhosis and mortality due to hepatopathy in patients from many regions worldwide. Chronic liver damage resulting from prolonged excessive alcohol consumption can lead to liver fibrosis, which may progress to cirrhosis and hepatocellular carcinoma. Strengthening awareness of the risks associated with ALD, abstaining from alcohol, and implementing early intervention are fundamental to the management of ALD. |
| Publish Date |
2024-09-26 08:22 |
| Citation |
Zhang XY, Chen QJ, Zhu F, Li M, Shang D. Dual peroxisome proliferator-activated receptor α/δ agonists: Hope for the treatment of alcohol-associated liver disease? World J Gastroenterol 2024; 30(37): 4163-4167 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i37/4163.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i37.4163 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
